quip announced Tuesday it raised $100 million in Series B funding from Cowen Sustainable Investments.

“quip is well on its way to becoming the iconic oral care brand in the way we’ve seen companies revolutionize other industries like fitness, pet care and eyewear. No other oral care company can match quip’s engaged customer base, data expertise, professional network and digital platform that helps people take control of every aspect of their oral health,” Ewa Kozicz, co-head of CSI, said in a statement.

The connected dental health company said it plans to use the capital to grow its consumer product line, create more professional services for its network of providers, expand globally and build out its leadership team.

quip, which launched in 2015, said it now has 7.5 million users and that it reached profitability in April 2020.

In 2019, the company released Quipcare, an app-based platform that allowed members to book dental care, and announced it was building a toothbrush specifically for kids. In 2018, quip landed $40 million in funding led by existing investor Sherpa Capital.

Eight Sleep, the maker of smart mattresses and other connected sleep gear, scooped up $86 million in Series C funding.

The round was led by Valor Equity Partners, with participation from other funds including SoftBank, Khosla Ventures, Founders Fund and General Catalyst.

The company said it plans to use the funds to speed up innovation and expand its team.

“Our end goal is to develop the most sophisticated technologies for restorative and preventative health, and this round helps us invest in building the team that will develop the next generation of Eight Sleep products,” cofounder and CEO Matteo Franceschetti said in a statement.

“Beyond our successful solutions for thermoregulation, we're working towards managing all of the factors that may disrupt users' rest to ensure everyone can improve sleep fitness for better health, performance and longevity.”

In 2019, the company announced it had raised $40 million. Eight Sleep said it has raised more than $150 million to date.

Alma, a platform that helps mental healthcare build their practices, announced it had raised $50 million in Series C funding.

The round was led by Insight Partners, with participation from Optum Ventures, Tusk Venture Partners, Primary Venture Partners, Sound Ventures, BoxGroup and Rainfall Ventures.

"At Alma, we're building a new model for mental healthcare that puts therapists at the forefront of everything we do," Alma founder and CEO Dr. Harry Ritter said in a statement.

"We can't talk about the $221 billion yearly mental health crisis without acknowledging the providers at the frontlines of this crisis. This past year we doubled down on tools and services to support our providers and scaled our insurance offering to make it easy and financially rewarding for providers to accept insurance. I'm proud to share that today 95% of our providers accept insurance, making the average in-network session incredibly affordable."

The need for mental healthcare has been a major concern during the COVID-19 pandemic. According to a report by the Kaiser Family Foundation using Census Bureau’s Household Pulse Survey, about four in 10 adults in the U.S. reported symptoms of anxiety or depressive disorder during the pandemic. 

Ellipsis Health, a company that uses vocal biomarkers to identify mental health disorders like anxiety and depression, raised $26 million in Series A funding.

The round was led by SJF Ventures with participation from AblePartners, Akhil Paul at Caparo Group, Alumni Ventures, Divesh Makan, Gaingels, Gary Loveman, Generator Ventures, Greycroft, Helmy Eltoukhy, Joanne Bradford, Khosla Ventures, Luminous Ventures, Marc Benioff’s TIME Ventures, Richard Socher, Ricardo Villela Marino, SpringTide Ventures and What If Ventures.

Ellipsis said the capital will be used to add more customers, grow global partnerships, build out its team and research new voice-based technology.

“Now more than ever, we need to prioritize the adoption of solutions that scale access to mental health awareness, diagnosis and evidence-based treatment,” Cody Nystrom, managing director with SJF Ventures, said in a statement. 

“To effect meaningful and urgent change, providers need efficient, scalable clinical decision support technology like Ellipsis Health to help identify and stratify patients so we can appropriately treat behavioral health conditions early and often.”

Earlier this month, Ellipsis and Cigna International announced the launch of their digital tool to evaluate a patient’s stress level. 

The company said it has raised $31 million in total funding.

Affect Therapeutics, a mobile platform for stimulant addiction recovery, announced it had raised $6 million in seed funding. 

Investors in this round included City Light Ventures, Kapor Capital, Acumen and AlleyCorp.

“The research for various stimulant use disorders has really focused on what is known as contingency management, which are incentives,” cofounder and CEO Kristin Muhlner told Forbes. “What we're looking to try to do in leveraging contingency management is to reignite the reward system in the brain, right after the drug has been eliminated.”

Joshin, a digital platform for disability care, closed a $3 million seed funding round led by Anthemis Group and the Autism Impact Fund.

The company plans to use the funding to expand its services into Los Angeles and Seattle, as well as broaden its corporate benefits program that allows employers to offer Joshin as a benefit to their employees. 

“For too long, people who have special health needs and their families have been underserved and had fragmented access to disability care providers,” CEO Melissa Danielsen said in a statement.

“The seed investment from Anthemis and the Autism Impact Fund enables Joshin to grow our network of care providers and expand our corporate care benefit programs. We’re continuing to scale our technology to lessen the burden of caregiving responsibilities for employees and their families.”